Doxorubicin 50

Doxorubicin 50 mg Injection
Doxorubicin 50 mg Injection is an anthracycline antineoplastic antibiotic widely used in the treatment of various cancers. It works by interfering with DNA replication and inhibiting topoisomerase II, leading to effective control of rapidly dividing cancer cells. Doxorubicin is a cornerstone drug in many standard chemotherapy regimens.
Product Details
Generic Name: Doxorubicin (as Doxorubicin Hydrochloride)
Strength: 50 mg
Dosage Form: Injection (Sterile solution / lyophilized powder for injection)
Route of Administration: Intravenous (IV)
Therapeutic Class: Anthracycline Anticancer Agent
Indications
Doxorubicin 50 mg Injection is indicated for the treatment of:
Breast cancer
Ovarian cancer
Lung cancer
Leukemia
Lymphomas (Hodgkin’s and Non-Hodgkin’s)
Multiple myeloma
Soft tissue and bone sarcomas
Mechanism of Action
Doxorubicin intercalates into DNA strands and inhibits topoisomerase II, preventing DNA replication and repair. It also generates free radicals that contribute to cancer cell death.
Key Benefits
Broad-spectrum anticancer activity
Widely used in combination chemotherapy regimens
Proven clinical efficacy across multiple malignancies
Established global oncology standard
Dosage & Administration
Dosage is individualized based on body surface area (BSA), cancer type, and patient condition. Doxorubicin should be administered only under strict medical supervision by qualified healthcare professionals.
Storage Conditions
Store at 2°C to 8°C (Refrigerated)
Protect from light
Do not freeze
Precautions
For hospital and oncology clinic use only
Cardiac function should be monitored regularly (risk of cardiotoxicity)
Monitor blood counts during treatment
Use with caution in patients with hepatic impairment